Myeloma is a blood cancer that starts in plasma cells, a type of white blood cell found in the bone marrow. It is commonly used to describe **multiple myeloma**, the most frequent form. Myeloma is discussed in oncology, hematology, radiology, pathology, and supportive cancer care because it can affect bones, kidneys, blood counts, and immunity. Care often involves both treating the cancer and preventing or managing complications.
Leukemia is a cancer that starts in blood-forming tissues, most often the bone marrow. It leads to abnormal blood cells that can crowd out normal blood production. Leukemia is a clinical diagnosis used in oncology and hematology to classify blood cancers and guide care. The term is commonly used in clinics, hospitals, and labs when blood counts or marrow tests suggest a blood-cell malignancy.
Lymphoma is a cancer that starts in lymphocytes, a type of white blood cell. It most often involves lymph nodes, but it can begin or spread in many organs. Lymphoma is commonly discussed in hematology-oncology clinics and cancer centers. The term covers several related diseases with different behaviors and treatments.
Sarcoma is a type of cancer that starts in connective tissues such as muscle, fat, nerves, blood vessels, cartilage, or bone. It is commonly discussed in oncology, surgery, radiation therapy, and pathology because diagnosis and treatment often require multiple specialties. Sarcoma care is used in both adult and pediatric cancer settings, depending on the subtype and the patient’s age.
Carcinoma is a type of cancer that starts in epithelial cells, the cells that line organs and body surfaces. It is one of the most common categories of cancer used in pathology and oncology. Clinicians use the term Carcinoma to describe many cancers of the skin, lung, breast, prostate, colon, and more. Carcinoma is a broad label that is refined by the organ involved and the tumor’s microscopic features.
Cancer is a group of diseases in which abnormal cells grow and can invade nearby tissues. It can start in almost any organ or tissue, including blood-forming tissues. It is commonly used as a diagnosis in medicine and as an umbrella term in oncology care. People may also use the word to describe treatment, services, and long-term follow-up after therapy.
A Tumor is an abnormal growth of cells that forms a lump or mass in the body. It can be benign (not cancer) or malignant (cancer). The term is commonly used in oncology, radiology, pathology, and surgery. It is also used in everyday language to describe a “growth,” even before a diagnosis is confirmed.
A Neoplasm is an abnormal growth of cells in the body. It can be benign (non-cancer) or malignant (cancer). The term is commonly used in pathology reports, imaging results, and oncology discussions. It helps clinicians describe a growth without assuming its behavior before full evaluation.
Malignancy is the medical term for a cancerous growth or cancer behavior in cells and tissues. It describes disease that can invade nearby structures and may spread (metastasize) to other parts of the body. Clinicians use Malignancy in pathology reports, imaging interpretations, cancer staging, and treatment planning. It is also used broadly to distinguish cancer from benign (non-cancerous) conditions.
A Lymphedema therapist is a clinician trained to evaluate and treat swelling caused by lymphatic system dysfunction. They most often help people with arm, leg, trunk, breast, head-and-neck, or genital swelling. They are commonly involved in cancer care after lymph node surgery, radiation therapy, or other treatments that affect lymph drainage. Their work focuses on symptom control, function, skin health, and long-term self-management education.